These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 28427180)
1. MMP-11 promoted the oral cancer migration and Fak/Src activation. Hsin CH; Chou YE; Yang SF; Su SC; Chuang YT; Lin SH; Lin CW Oncotarget; 2017 May; 8(20):32783-32793. PubMed ID: 28427180 [TBL] [Abstract][Full Text] [Related]
2. MMP-9 Knockdown Inhibits Oral Squamous Cell Carcinoma Lymph Node Metastasis in the Nude Mouse Tongue-Xenografted Model through the RhoC/Src Pathway. Yin P; Su Y; Chen S; Wen J; Gao F; Wu Y; Zhang X Anal Cell Pathol (Amst); 2021; 2021():6683391. PubMed ID: 33828938 [TBL] [Abstract][Full Text] [Related]
3. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma. Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593 [TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion. Pramanik KK; Nagini S; Singh AK; Mishra P; Kashyap T; Nath N; Alam M; Rana A; Mishra R Cell Oncol (Dordr); 2018 Feb; 41(1):47-60. PubMed ID: 29134466 [TBL] [Abstract][Full Text] [Related]
5. TRIB1 promotes colorectal cancer cell migration and invasion through activation MMP-2 via FAK/Src and ERK pathways. Wang Y; Wu N; Pang B; Tong D; Sun D; Sun H; Zhang C; Sun W; Meng X; Bai J; Chen F; Geng J; Fu S; Jin Y Oncotarget; 2017 Jul; 8(29):47931-47942. PubMed ID: 28624785 [TBL] [Abstract][Full Text] [Related]
6. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959 [TBL] [Abstract][Full Text] [Related]
8. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC). Pramanik KK; Mishra R Exp Cell Res; 2022 Feb; 411(1):112984. PubMed ID: 34951997 [TBL] [Abstract][Full Text] [Related]
9. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma. Jiang T; Xie P; Liu H J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036 [TBL] [Abstract][Full Text] [Related]
10. Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma. Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Umeda M; Nemoto TK; Kurita H Pathol Oncol Res; 2016 Jul; 22(3):625-32. PubMed ID: 26874697 [TBL] [Abstract][Full Text] [Related]
11. Abnormal expression of FAK and paxillin correlates with oral cancer invasion and metastasis. Song M; Hu J; Quan HY Acta Biochim Pol; 2021 Apr; 68(2):317-323. PubMed ID: 33860659 [TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas]. Xu H; Shi XP; Tang WP; Li LX Ai Zheng; 2002 Sep; 21(9):983-8. PubMed ID: 12508547 [TBL] [Abstract][Full Text] [Related]
13. Elucidating the Role of Let-7d-5p and OLR1 in the Progression and Prognosis of Oral Squamous Cell Carcinoma Lin CH; Chiang CC; Shih YC; Tung SL; Huang WC Anticancer Res; 2024 Jun; 44(6):2517-2531. PubMed ID: 38821588 [TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691 [TBL] [Abstract][Full Text] [Related]
15. Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment. Routray S; Kheur S; Chougule HM; Mohanty N; Dash R Ann Diagn Pathol; 2017 Oct; 30():36-41. PubMed ID: 28965626 [TBL] [Abstract][Full Text] [Related]
16. Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer. Ogbureke KU; Nikitakis NG; Warburton G; Ord RA; Sauk JJ; Waller JL; Fisher LW Oral Oncol; 2007 Oct; 43(9):920-32. PubMed ID: 17306612 [TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma. Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392 [TBL] [Abstract][Full Text] [Related]
18. High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis. Pu Y; Wang L; Wu H; Feng Z; Wang Y; Guo C Oncol Rep; 2014 Jun; 31(6):2644-50. PubMed ID: 24700287 [TBL] [Abstract][Full Text] [Related]
19. Cyr61 increases matrix metalloproteinase-3 expression and cell motility in human oral squamous cell carcinoma cells. Chuang JY; Yu NY; Chiang IP; Lai CH; Lin CD; Tang CH J Cell Biochem; 2012 Jun; 113(6):1977-86. PubMed ID: 22253074 [TBL] [Abstract][Full Text] [Related]
20. [The correlation between neck lymphy node metastasis and matrixmetalloproteinase-2 expression at the invasive tumor front of oral squamous cell carcinomas]. Liu LK; Li YN; Jiang HB; He ZX; Yi XZ Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):106-8. PubMed ID: 15190788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]